ARM
CNO icon

Adirondack Research & Management’s CNO Financial Group CNO Stock Holding History

Adirondack Research & Management’s Portfolio CNO Stock Details CNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1.88M Hold
79,920
– – 2.29% 3
2021
Q2 		$1.89M Sell
79,920
-6,101
-7% -$156K 2.21% 4
2021
Q1 		$2.09M Buy
86,021
+4,500
+6% +$107K 2.47% 4
2020
Q4 		$1.81M Sell
81,521
-77,030
-49% -$1.57M 2.48% 8
2020
Q3 		$2.54M Sell
158,551
-14,700
-8% -$236K 3.54% 2
2020
Q2 		$2.7M Sell
173,251
-15,000
-8% -$207K 3.54% 5
2020
Q1 		$2.33M Hold
188,251
– – 3.25% 6
2019
Q4 		$3.41M Buy
188,251
+2,500
+1% +$42.5K 2.96% 7
2019
Q3 		$2.94M Buy
185,751
+5,554
+3% +$87.8K 2.57% 10
2019
Q2 		$3.01M Buy
180,197
+6,500
+4% +$107K 2.15% 14
2019
Q1 		$2.81M Hold
173,697
– – 1.75% 25
2018
Q4 		$2.58M Buy
173,697
+15,000
+9% +$274K 1.62% 23
2018
Q3 		$3.37M Buy
158,697
+3,000
+2% +$63K 1.26% 36
2018
Q2 		$2.96M Hold
155,697
– – 1.16% 42
2018
Q1 		$3.37M Buy
+155,697
New +$3.67M 1.35% 35
2017
Q4 		– Sell
-224,996
Closed -$5.25M – 109
2017
Q3 		$5.25M Hold
224,996
– – 2.05% 12
2017
Q2 		$4.7M Hold
224,996
– – 1.83% 18
2017
Q1 		$4.61M Hold
224,996
– – 1.66% 22
2016
Q4 		$4.31M Buy
224,996
+1,200
+0.5% +$20.6K 1.46% 32
2016
Q3 		$3.42M Sell
223,796
-8,910
-4% -$145K 1.23% 38
2016
Q2 		$4.06M Hold
232,706
– – 1.52% 31
2016
Q1 		$4.17M Hold
232,706
– – 1.51% 26
2015
Q4 		$4.44M Hold
232,706
– – 1.61% 26
2015
Q3 		$4.38M Hold
232,706
– – 1.68% 20
2015
Q2 		$4.27M Hold
232,706
– – 1.57% 24
2015
Q1 		$4.01M Sell
232,706
-25,020
-10% -$412K 1.55% 30
2014
Q4 		$4.44M Hold
257,726
– – 1.66% 20
2014
Q3 		$4.37M Buy
+257,726
New +$4.44M 1.62% 22
2014
Q2 		– Sell
-257,726
Closed -$4.67M – 99
2014
Q1 		$4.67M Hold
257,726
– – 1.78% 15
2013
Q4 		$4.56M Sell
257,726
-9,665
-4% -$155K 2.21% 2
2013
Q3 		$3.85M Buy
267,391
+22,913
+9% +$327K 2.22% 2
2013
Q2 		$3.17M Buy
+244,478
New +$2.89M 2.36% 3

Other funds holding CNO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Adirondack Research & Management's CNO Position: Q3 2021 in Review

Adirondack Research & Management held its CNO Financial Group (CNO) position steady in Q3 2021 at 79,920 shares worth $1.88M. The position accounts for 2.29% of the portfolio, ranked #3.

Adirondack Research & Management first reported a position in CNO in Q2 2013 and has held it in 32 quarters since. The position peaked at $5.25M in Q3 2017. 244 funds tracked by Wall St. Rank hold CNO as of Q3 2021.

  • Adirondack Research & Management held 79,920 shares of CNO Financial Group worth $1.88M as of Q3 2021.
  • Adirondack Research & Management left its CNO Financial Group share count unchanged in Q3 2021.
  • CNO Financial Group made up 2.29% of Adirondack Research & Management's portfolio in Q3 2021, its #3 holding.
  • Adirondack Research & Management first reported a position in CNO Financial Group in Q2 2013 and has held it in 32 quarters since.
  • Adirondack Research & Management's CNO Financial Group position peaked at $5.25M in Q3 2017.
  • 244 funds tracked by Wall St. Rank held CNO Financial Group as of Q3 2021.

Based on Adirondack Research & Management's 13F filing for Q3 2021, filed 29 Oct 2021.